Prasugrel Use Following PCI and Associated Patient Outcomes: Insights From the National VA CART Program

ConclusionsPrasugrel use after PCI in the Veterans Administration is low and prasugrel was rarely used in contraindicated or high‐bleeding‐risk settings. However, a third of patients received prasugrel for off‐label non‐ACS indications that lack efficacy data.

Source: Clinical Cardiology - October 26, 2016 Category: Cardiology Authors: Vikas Aggarwal, Ehrin J. Armstrong, Wenhui Liu, Thomas M. Maddox, P. Michael Ho, Evan Carey, Tracy Wang, Matthew Sherwood, Thomas T. Tsai, John S. Rumsfeld, Steven M. Bradley Tags: Clinical Investigations Source Type: research